Search
for
Sort by
Research 181–210 of 1000+
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- The genetically programmed hair growth cycle and alopecia: what is there to know?
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Nosological profile of dermatological diseases in primary health care and dermatology secondary care in Florianópolis (2016–2017)
- Dermatologic Adverse Events from Cancer Treatments
- Current and future pharmacotherapy for alopecia areata
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Dermatologic Care of the Transplant Patient
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Differential diagnosis of alopetia in children and adolescents
- Optimizing skin disease diagnosis: harnessing online community data with contrastive learning and clustering techniques
- Janus Kinase inhibitors in dermatology: a review
- New therapies for alopecia areata
- Cicatricial Alopecia
- Alternative Medicine for Hair Loss
- Psikonöroimmünoloji ve Multifaktöryel Psikodermatolojik Hastalıklar
- Cutaneous drug reactions
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Spectrum and clinical burden of Unrecognized Dermatologic Diseases in hospitalized adults: A single-centre cross-sectional study
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Prevalence and Clinical Spectrum of Dermatologic Conditions in Renal Transplant Recipients: A 10-Year Retrospective Cross-Sectional Study
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- A cross sectional study on geriatric dermatosis in patients attending a tertiary care hospital
- Geriatric Dermatologic Therapy
- Epidemiology and burden of alopecia areata in Taiwan: a systematic review